Association of BDNF and BCHE with Alzheimer's disease: Meta‑analysis based on 56 genetic case‑control studies of 12,563 cases and 12,622 controls

Ji,Huihui; Dai,Dongjun; Wang,Yunliang; Jiang,Danjie; Zhou,Xingyu; Lin,Peipei; Ji,Xiaosui; Li,Jinfeng; Zhang,Yuzheng; Yin,Honglei; Chen,Rongrong; Zhang,Lina; Xu,Mingqing; Duan,Shiwei; Wang,Qinwen

doi:10.3892/etm.2015.2327

Association of BDNF and BCHE with Alzheimer's disease: Meta‑analysis based on 56 genetic case‑control studies of 12,563 cases and 12,622 controls

Authors:
- Huihui Ji
- Dongjun Dai
- Yunliang Wang
- Danjie Jiang
- Xingyu Zhou
- Peipei Lin
- Xiaosui Ji
- Jinfeng Li
- Yuzheng Zhang
- Honglei Yin
- Rongrong Chen
- Lina Zhang
- Mingqing Xu
- Shiwei Duan
- Qinwen Wang
View Affiliations

Affiliations: Zhejiang Provincial Key Laboratory of Pathophysiology, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China, Department of Neurology, The 148 Central Hospital of PLA, Zibo, Shandong 255300, P.R. China, Bio‑X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai 20030, P.R. China
Published online on: March 3, 2015 https://doi.org/10.3892/etm.2015.2327
Pages: 1831-1840

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Alzheimer's disease (AD) is a common neurodegenerative disorder that can destroy the memory of sufferers and lead to distress for the individual and society. Brain‑derived neurotrophic factor (BDNF) and butyrylcholinesterase (BCHE) are two genes associated with β‑amyloid plaques and neurofibrillary tangles that are two key factors in the pathophysiology of AD. The aim of the current meta‑analysis was to evaluate the association between BDNF Val66Met (rs6265), BDNF C270T (rs2030324) and BCHE‑K (rs1803274) polymorphisms and AD. A comprehensive meta‑analysis was performed using the online database PubMed without a time limitation. A total of 56 articles evaluating 12,563 cases and 12,622 controls were selected for the current meta‑analysis. The results showed a moderate association of the BDNF C270T polymorphism with the risk of AD in Asians under a dominant model (P=0.03; odds ratio, 1.88; 95% confidence interval, 1.08‑3.27). No other significant association was found during the meta‑analysis for the other two polymorphisms (P>0.05). The current meta‑analysis suggests that BDNF C270T is a risk factor for AD in Asians. This meta‑analysis has been, to the best of our knowledge, the most comprehensive meta‑analysis of BDNF Val66Met, BDNF C270T and BCHE‑K to date.

View Figures

View References

1	Mucke L: Neuroscience: Alzheimer's disease. Nature. 461:895–897. 2009. View Article : Google Scholar : PubMed/NCBI
2	Brookmeyer R, Johnson E, Ziegler-Graham K and Arrighi HM: Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 3:186–191. 2007. View Article : Google Scholar : PubMed/NCBI
3	Armstrong RA: What causes Alzheimer's disease. Folia Neuropathol. 51:169–188. 2013. View Article : Google Scholar : PubMed/NCBI
4	Bertram L and Tanzi RE: Genome-wide association studies in Alzheimer's disease. Hum Mol Genet. 18:R137–R145. 2009. View Article : Google Scholar : PubMed/NCBI
5	Scacchi R, Gambina G, Moretto G and Corbo RM: Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine. Am J Med Genet B Neuropsychiatr Genet. 150B:502–507. 2009. View Article : Google Scholar : PubMed/NCBI
6	Borroni B, Costanzi C and Padovani A: Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease. Curr Alzheimer Res. 7:158–164. 2010. View Article : Google Scholar : PubMed/NCBI
7	Serretti A, Olgiati P and De Ronchi D: Genetics of Alzheimer's disease. A rapidly evolving field. J Alzheimers Dis. 12:73–92. 2007.PubMed/NCBI
8	Maisonpierre PC, Le Beau MM, Espinosa R III, Ip NY, Belluscio L, de la Monte SM, Squinto S, Furth ME and Yancopoulos GD: Human and rat brain-derived neurotrophic factor and neurotrophin-3: Gene structures, distributions, and chromosomal localizations. Genomics. 10:558–568. 1991. View Article : Google Scholar : PubMed/NCBI
9	Ferrer I, Marín C, Rey MJ, Ribalta T, Goutan E, Blanco R, Tolosa E and Martí E: BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol. 58:729–739. 1999. View Article : Google Scholar : PubMed/NCBI
10	Aicardi G, Argilli E, Cappello S, Santi S, Riccio M, Thoenen H and Canossa M: Induction of long-term potentiation and depression is reflected by corresponding changes in secretion of endogenous brain-derived neurotrophic factor. Proc Natl Acad Sci USA. 101:15788–15792. 2004. View Article : Google Scholar : PubMed/NCBI
11	Poo MM: Neurotrophins as synaptic modulators. Nat Rev Neurosci. 2:24–32. 2001. View Article : Google Scholar : PubMed/NCBI
12	Ventriglia M, Bocchio Chiavetto L, Benussi L, Binetti G, Zanetti O, Riva MA and Gennarelli M: Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol Psychiatry. 7:136–137. 2002. View Article : Google Scholar : PubMed/NCBI
13	Saarela MS, Lehtimaki T, Rinne JO, Huhtala H, Rontu R, Hervonen A, Roytta M, Ahonen JP and Mattila KM: No association between the brain-derived neurotrophic factor 196 G>;A or 270 C>T polymorphisms and Alzheimer's or Parkinson's disease. Folia Neuropathol. 44:12–16. 2006.PubMed/NCBI
14	Fehér A, Juhász A, Rimanóczy A, Kálmán J and Janka Z: Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease. Alzheimer Dis Assoc Disord. 23:224–228. 2009. View Article : Google Scholar : PubMed/NCBI
15	Pivac N, Nikolac M, Nedic G, et al: Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry. 35:356–362. 2011. View Article : Google Scholar : PubMed/NCBI
16	Matsushita S, Arai H, Matsui T, Yuzuriha T, Urakami K, Masaki T and Higuchi S: Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease. J Neural Transm. 112:703–711. 2005. View Article : Google Scholar : PubMed/NCBI
17	Olin D, MacMurray J and Comings DE: Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism. Neurosci Lett. 381:275–278. 2005. View Article : Google Scholar : PubMed/NCBI
18	Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, Nabika T, Kobayashi S and Nanko S: A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry. 6:83–86. 2001. View Article : Google Scholar : PubMed/NCBI
19	Nishimura M, Kuno S, Kaji R and Kawakami H: Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy. Mov Disord. 20:1031–1033. 2005. View Article : Google Scholar : PubMed/NCBI
20	Allderdice PW, Gardner HA, Galutira D, Lockridge O, LaDu BN and McAlpine PJ: The cloned butyrylcholinesterase (BCHE) gene maps to a single chromosome site, 3q26. Genomics. 11:452–454. 1991. View Article : Google Scholar : PubMed/NCBI
21	Arpagaus M, Kott M, Vatsis KP, Bartels CF, La Du BN and Lockridge O: Structure of the gene for human butyrylcholinesterase. Evidence for a single copy. Biochemistry. 29:124–131. 1990. View Article : Google Scholar : PubMed/NCBI
22	Perry E, McKeith I and Ballard C: Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodies. Neurology. 60:1852–1853. 2003. View Article : Google Scholar : PubMed/NCBI
23	Arendt T, Brückner MK, Lange M and Bigl V: Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development - a study of molecular forms. Neurochem Int. 21:381–396. 1992. View Article : Google Scholar : PubMed/NCBI
24	Carson KA, Geula C and Mesulam MM: Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue. Brain Res. 540:204–208. 1991. View Article : Google Scholar : PubMed/NCBI
25	Darvesh S, Cash MK, Reid GA, Martin E, Mitnitski A and Geula C: Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease. J Neuropathol Exp Neurol. 71:2–14. 2012. View Article : Google Scholar : PubMed/NCBI
26	Nacmias B, Piccini C, Bagnoli S, Tedde A, Cellini E, Bracco L and Sorbi S: Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer's disease. Neurosci Lett. 367:379–383. 2004. View Article : Google Scholar : PubMed/NCBI
27	Combarros O, Infante J, Llorca J and Berciano J: Polymorphism at codon 66 of the brain-derived neurotrophic factor gene is not associated with sporadic Alzheimer's disease. Dement Geriatr Cogn Disord. 18:55–58. 2004. View Article : Google Scholar : PubMed/NCBI
28	Lee J, Fukumoto H, Orne J, Klucken J, Raju S, Vanderburg CR, Irizarry MC, Hyman BT and Ingelsson M: Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms. Exp Neurol. 194:91–96. 2005. View Article : Google Scholar : PubMed/NCBI
29	Desai P, Nebes R, DeKosky ST and Kamboh MI: Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression. Neurosci Lett. 379:229–234. 2005. View Article : Google Scholar : PubMed/NCBI
30	Vepsӓlӓinen S, Castren E, Helisalmi S, Iivonen S, Mannermaa A, Lehtovirta M, Hӓnninen T, Soininen H and Hiltunen M: Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease. J Neurol. 252:423–428. 2005. View Article : Google Scholar : PubMed/NCBI
31	Bodner SM, Berrettini W, van Deerlin V, Bennett DA, Wilson RS, Trojanowski JQ and Arnold SE: Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 134B:1–5. 2005. View Article : Google Scholar : PubMed/NCBI
32	Li Y, Rowland C, Tacey K, et al: The BDNF Val66Met polymorphism is not associated with late onset Alzheimer's disease in three case-control samples. Mol Psychiatry. 10:809–810. 2005. View Article : Google Scholar : PubMed/NCBI
33	Forero DA, Benítez B, Arboleda G, Yunis JJ, Pardo R and Arboleda H: Analysis of functional polymorphisms in three synaptic plasticity-related genes (BDNF, COMT AND UCHL1) in Alzheimer's disease in Colombia. Neurosci Res. 55:334–341. 2006. View Article : Google Scholar : PubMed/NCBI
34	Zhang H, Ozbay F, Lappalainen J, et al: Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am J Med Genet B Neuropsychiatr Genet. 141B:387–393. 2006. View Article : Google Scholar : PubMed/NCBI
35	Huang R, Huang J, Cathcart H, Smith S and Poduslo SE: Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease. J Med Genet. 44:e662007. View Article : Google Scholar : PubMed/NCBI
36	Boiocchi C, Maggioli E, Zorzetto M, Sinforiani E, Cereda C, Ricevuti G and Cuccia M: Brain-derived neurotrophic factor gene variants and Alzheimer disease: An association study in an Alzheimer disease Italian population. Rejuvenation Res. 16:57–66. 2013. View Article : Google Scholar : PubMed/NCBI
37	Cozza A, Melissari E, Iacopetti P, Mariotti V, Tedde A, Nacmias B, Conte A, Sorbi S and Pellegrini S: SNPs in neurotrophin system genes and Alzheimer's disease in an Italian population. J Alzheimers Dis. 15:61–70. 2008.PubMed/NCBI
38	Tsai SJ, Hong CJ, Liu HC, Liu TY, Hsu LE and Lin CH: Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer's disease and age of onset. Neuropsychobiology. 49:10–12. 2004. View Article : Google Scholar : PubMed/NCBI
39	Bian JT, Zhang JW, Zhang ZX and Zhao HL: Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland China. Neurosci Lett. 387:11–16. 2005. View Article : Google Scholar : PubMed/NCBI
40	Akatsu H, Yamagata HD, Kawamata J, Kamino K, Takeda M, Yamamoto T, Miki T, Tooyama I, Shimohama S and Kosaka K: Variations in the BDNF gene in autopsy-confirmed Alzheimer's disease and dementia with Lewy bodies in Japan. Dement Geriatr Cogn Disord. 22:216–222. 2006. View Article : Google Scholar : PubMed/NCBI
41	Tsai SJ, Hong CJ, Liu HC, Liu TY and Liou YJ: The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a Chinese population. Dement Geriatr Cogn Disord. 21:139–143. 2006. View Article : Google Scholar : PubMed/NCBI
42	He XM, Zhang ZX, Zhang JW, Zhou YT, Tang MN, Wu CB and Hong Z: Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population. Neuropsychobiology. 55:151–155. 2007. View Article : Google Scholar : PubMed/NCBI
43	Riemenschneider M, Schwarz S, Wagenpfeil S, Diehl J, Müller U, Förstl H and Kurz A: A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Mol Psychiatry. 7:782–785. 2002. View Article : Google Scholar : PubMed/NCBI
44	Nishimura AL, Oliveira JR, Mitne-Neto M, Guindalini C, Nitrini R, Bahia VS, de Brito-Marques PR, Otto PA and Zatz M: Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer's disease (LOAD) in Brazilian patients. J Mol Neurosci. 22:257–260. 2004. View Article : Google Scholar : PubMed/NCBI
45	Cousin E, Macé S, Rocher C, et al: No replication of genetic association between candidate polymorphisms and Alzheimer's disease. Neurobiol Aging. 32:1443–1451. 2011. View Article : Google Scholar : PubMed/NCBI
46	Combarros O, Riancho JA, Infante J, Sañudo C, Llorca J, Zarrabeitia MT and Berciano J: Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk. Dement Geriatr Cogn Disord. 20:153–157. 2005. View Article : Google Scholar : PubMed/NCBI
47	Raygani AV, Zahrai M, Soltanzadeh A, Doosti M, Javadi E and Pourmotabbed T: Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease. Neurosci Lett. 371:142–146. 2004. View Article : Google Scholar : PubMed/NCBI
48	Alvarez-Arcaya A, Combarros O, Llorca J, Sánchez-Guerra M, Berciano J, Fernández-Viadero C and Peña N: The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women. Acta Neurol Scand. 102:350–353. 2000. View Article : Google Scholar : PubMed/NCBI
49	McIlroy SP, Crawford VL, Dynan KB, McGleenon BM, Vahidassr MD, Lawson JT and Passmore AP: Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland. J Med Genet. 37:182–185. 2000. View Article : Google Scholar : PubMed/NCBI
50	Wiebusch H, Poirier J, Sévigny P and Schappert K: Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease. Hum Genet. 104:158–163. 1999. View Article : Google Scholar : PubMed/NCBI
51	Lehmann DJ, Johnston C and Smith AD: Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum Mol Genet. 6:1933–1936. 1997. View Article : Google Scholar : PubMed/NCBI
52	Simão-Silva DP, Bertolucci PH, de Labio RW, Payão SL, Furtado-Alle L and Souza RL: Association analysis between K and −116A variants of butyrylcholinesterase and Alzheimer's disease in a Brazilian population. Chem Biol Interact. 203:358–360. 2013. View Article : Google Scholar : PubMed/NCBI
53	Mateo I, Llorca J, Infante J, Rodríguez-Rodríguez E, Berciano J and Combarros O: Gene-gene interaction between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer's disease risk. Eur J Neurol. 15:219–222. 2008. View Article : Google Scholar : PubMed/NCBI
54	Déniz-Naranjo MC, Muñoz-Fernández C, Alemany-Rodríguez MJ, del Carmen Pérez-Vieitez M, Aladro-Benito Y, Irurita-Latasa J and Sánchez-García F: Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain). Neurosci Lett. 427:34–38. 2007. View Article : Google Scholar : PubMed/NCBI
55	Piccardi M, Congiu D, Squassina A, Manconi F, Putzu PF, Mereu RM, Chillotti C and Del Zompo M: Alzheimer's disease: Case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample. Am J Med Genet B Neuropsychiatr Genet. 144B:895–899. 2007. View Article : Google Scholar : PubMed/NCBI
56	Prince JA, Feuk L, Sawyer SL, Gottfries J, Ricksten A, Nӓgga K, Bogdanovic N, Blennow K and Brookes AJ: Lack of replication of association findings in complex disease: An analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet. 9:437–444. 2001. View Article : Google Scholar : PubMed/NCBI
57	Mattila KM, Rinne JO, Röyttӓ M, Laippala P, Pietilӓ T, Kalimo H, Koivula T, Frey H and Lehtimӓki T: Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology. J Med Genet. 37:766–770. 2000. View Article : Google Scholar : PubMed/NCBI
58	Tilley L, Morgan K, Grainger J, Marsters P, Morgan L, Lowe J, Xuereb J, Wischik C, Harrington C and Kalsheker N: Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease. Eur J Hum Genet. 7:659–663. 1999. View Article : Google Scholar : PubMed/NCBI
59	Grubber JM, Saunders AM, Crane-Gatherum AR, et al: Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K). Neurosci Lett. 269:115–119. 1999. View Article : Google Scholar : PubMed/NCBI
60	Kehoe PG, Williams H, Holmans P, Wilcock G, Cairns NJ, Neal J and Owen MJ: The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease. J Med Genet. 35:1034–1035. 1998. View Article : Google Scholar : PubMed/NCBI
61	Hiltunen M, Mannermaa A, Helisalmi S, Koivisto A, Lehtovirta M, Ryynӓnen M, Riekkinen P and Soininen H: Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients. Neurosci Lett. 250:69–71. 1998. View Article : Google Scholar : PubMed/NCBI
62	Crawford F, Fallin D, Suo Z, Abdullah L, Gold M, Gauntlett A, Duara R and Mullan M: The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations. Neurosci Lett. 249:115–118. 1998. View Article : Google Scholar : PubMed/NCBI
63	Singleton AB, Smith G, Gibson AM, Woodward R, Perry RH, Ince PG, Edwardson JA and Morris CM: No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Hum Mol Genet. 7:937–939. 1998. View Article : Google Scholar : PubMed/NCBI
64	Brindle N, Song Y, Rogaeva E, et al: Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease. Hum Mol Genet. 7:933–935. 1998. View Article : Google Scholar : PubMed/NCBI
65	Russ C, Powell J, Lovestone S and Holmes C: K variant of butyrycholinesterase and late-onset Alzheimer's disease. Lancet. 351:8811998. View Article : Google Scholar : PubMed/NCBI
66	Helbecque N: The butyrylcholinesterase K variant is not associated with Alzheimer's. Alzheimers Rep. 1:309–313. 1998.
67	Laws SM: Evidence that the butyrylcholinesterase K variant can protect against late-onset Alzheimer's disease. Alzheimers Rep. 2:219–223. 1999.
68	Bi S, Zhang Y, Wu J, Wang D and Zhao Q: Association between low-density lipoprotein receptor-related protein gene, butyrylcholinesterase gene and Alzheimer's disease in Chinese. Chin Med Sci J. 16:71–75. 2001.PubMed/NCBI
69	Lee DW, Liu HC, Liu TY, Chi CW and Hong CJ: No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese. Am J Med Genet. 96:167–169. 2000. View Article : Google Scholar : PubMed/NCBI
70	Yamamoto Y, Yasuda M, Mori E and Maeda K: Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 67:94–96. 1999. View Article : Google Scholar : PubMed/NCBI
71	Ki CS, Na DL, Kim JW, Kim HJ, Kim DK and Yoon BK: No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease. Am J Med Genet. 88:113–115. 1999. View Article : Google Scholar : PubMed/NCBI
72	Yamada M, Sodeyama N, Itoh Y, Suematsu N, Otomo E, Matsushita M and Mizusawa H: Butyrylcholinesterase K variant and cerebral amyloid angiopathy. Stroke. 29:2488–2490. 1998. View Article : Google Scholar : PubMed/NCBI
73	Xu X, Wang Y, Wang L, et al: Meta-analyses of 8 polymorphisms associated with the risk of the Alzheimer's disease. PLoS One. 8:e731292013. View Article : Google Scholar : PubMed/NCBI
74	Dai D, Wang Y, Wang L, et al: Polymorphisms of DRD2 and DRD3 genes and Parkinson's disease: A meta-analysis. Biomed Rep. 2:275–281. 2014.PubMed/NCBI
75	Zhou J, Huang Y, Huang RS, et al: A case-control study provides evidence of association for a common SNP rs974819 in PDGFD to coronary heart disease and suggests a sex-dependent effect. Thromb Res. 130:602–606. 2012. View Article : Google Scholar : PubMed/NCBI
76	Excoffier L, Laval G and Schneider S: Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online. 1:47–50. 2005.
77	Gibson E, Fenster A and Ward AD: The impact of registration accuracy on imaging validation study design: A novel statistical power calculation. Med Image Anal. 17:805–815. 2013. View Article : Google Scholar : PubMed/NCBI
78	Coory MD: Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 39:932–933. 2010. View Article : Google Scholar : PubMed/NCBI
79	Kawalec P, Mikrut A, Wiśniewska N and Pilc A: The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol. 32:1415–1424. 2013. View Article : Google Scholar : PubMed/NCBI
80	McHughen SA, Rodriguez PF, Kleim JA, Kleim ED, Marchal Crespo L, Procaccio V and Cramer SC: BDNF val66met polymorphism influences motor system function in the human brain. Cereb Cortex. 20:1254–1262. 2010. View Article : Google Scholar : PubMed/NCBI
81	Pezawas L, Verchinski BA, Mattay VS, Callicott JH, Kolachana BS, Straub RE, Egan MF, Meyer-Lindenberg A and Weinberger DR: The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci. 24:10099–10102. 2004. View Article : Google Scholar : PubMed/NCBI
82	Fukumoto N, Fujii T, Combarros O, et al: Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer's disease: New data and meta-analysis. Am J Med Genet B Neuropsychiatr Genet. 153B:235–242. 2010.PubMed/NCBI
83	Nagata T, Shinagawa S, Nukariya K, Ochiai Y, Kawamura S, Agawa-Ohta M, Kasahara H, Nakayama K and Yamada H: Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease. Psychogeriatrics. 11:141–149. 2011. View Article : Google Scholar : PubMed/NCBI
84	Guillozet AL, Smiley JF, Mash DC and Mesulam MM: Butyrylcholinesterase in the life cycle of amyloid plaques. Ann Neurol. 42:909–918. 1997. View Article : Google Scholar : PubMed/NCBI
85	Lehmann DJ, Nagy Z, Litchfield S, Borja MC and Smith AD: Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease. Hum Genet. 106:447–452. 2000. View Article : Google Scholar : PubMed/NCBI
86	Lehmann DJ, Williams J, McBroom J and Smith AD: Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups. Neuroscience. 108:541–554. 2001. View Article : Google Scholar : PubMed/NCBI